Abstract:Objective To investigate the correlation between the expression level of serum miR-4286 and clinicopathological characteristics of gastric cancer, and analyze its efficacy and significance in clinical diagnosis of gastric cancer. Methods Real time fluorescence quantitative PCR was used to detect the expression of miR-4286 in serum samples of healthy control group and gastric cancer group. The correlation between the expression of miR-4286 and the clinicopathological features of gastric cancer was analyzed by statistical methods; Diagnostic efficacy of miR- 4286 for gastric cancer was assessed by receiver operating characteristic curve and risk score analysis; Expression of tumor markers CEA, CA19-9, and CA72-4 were detected by electrochemiluminescence immunoassay. Results The expression of miR-4286 in the serum of gastric cancer group was higher than that in healthy control group (Z =-4.644, P < 0.0001). The expression level of miR-4286 in gastric cancer group was not related to tumor clinical stage, lymph node metastasis and distant metastasis (P > 0.05), but it was negatively correlated with the degree of pathological differentiation of tumor cells (Z =-2.661, P < 0.01). Compared with the control group, there was no significant difference in the expression of CEA and CA19-9 in the serum of gastric cancer group (P > 0.05), but the expression of CA72-4 was increased (Z =-3.324, P < 0.01). The area under the curve of miR-4286 for diagnosing gastric cancer was 0.727, and its specificity and positive predictive value were 90% and 0.872, respectively, which was higher than that of tumor marker CA72-4. Conclusions MiR-4286 is highly expressed in gastric cancer serum, and its expression level is negatively correlated with pathological differentiation. It may be a potential diagnostic marker for gastric cancer.